Skip to main content
Clinical Trials/NCT00991367
NCT00991367CompletedPhase 3

Efficacy of CICATRIX (Asian Gotu Kola or Pennywort) in the Treatment of Recent Post-surgical Scars

Catalysis SL2 sites in 1 country90 target enrollmentStarted: October 2009Last updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
90
Locations
2
Primary Endpoint
Length of the post-surgical scar(s) measured by a millimetric ruler at week 4 (end of the treatment)

Study Overview

Brief Summary

The purpose of the study is to assess the efficacy of CICATRIX (Asian Gotu Kola or Pennywort) usage in the treatment of recent post-surgical scars. The duration of this double-blind placebo controlled phase 3 clinical trial will be 4 weeks. The estimated number of persons to be recruited and randomized for the study is 90.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
18 Years to 55 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Recent (less than 48 hours) post-surgical wound

Exclusion Criteria

  • Post-surgical wound with sepsis
  • Usage of steroids within 30 days
  • Malignant neoplastic conditions
  • Alcoholism
  • Handicap and/or psychiatric condition preventing treatment accomplishment.

Outcomes

Primary Outcomes

Length of the post-surgical scar(s) measured by a millimetric ruler at week 4 (end of the treatment)

Time Frame: 4 weeks

Secondary Outcomes

  • Occurrence of adverse effects at week 4 (end of the treatment)(4 weeks)
  • Photographs of lesions at week 4 (end of the treatment)(4 weeks)

Investigators

Sponsor Class
Industry

Study Sites (2)

Loading locations...

Similar Trials